Reliv Intl Inc (RELV) 0.57 $RELV Reliv International

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Reliv Intl Inc (RELV) 0.57 $RELV

Reliv International Reports First-Quarter Financial Results for 2016
Marketwire Canada - Fri May 13, 6:00AM CDT
CHESTERFIELD, MO --(Marketwired - May 13, 2016) - Reliv International, Inc. (NASDAQ: RELV), a maker of nutritional supplements that promote optimal health, today reported its financial results for the first quarter of 2016.
RELV: 0.57 (-0.06)

Reliv International Reports Fourth-Quarter and Full-Year Financial Results for 2015
Marketwired - Thu Mar 24, 6:01AM CDT
Reliv International, Inc. (NASDAQ: RELV), a maker of nutritional supplements that promote optimal health, today reported its financial results for the fourth quarter and full year of 2015.
RELV: 0.57 (-0.06)

Reliv International, Inc. Announces $500,000 Stock Repurchase Program
Marketwired - Fri Dec 11, 6:00AM CST
Reliv International, Inc. (NASDAQ: RELV) announced today that its Board of Directors has authorized a stock repurchase program of up to $500,000 of the company's outstanding common stock.
RELV: 0.57 (-0.06)

Reliv International Reports Third-Quarter Financial Results
Marketwired - Fri Nov 13, 6:00AM CST
Reliv International, Inc. (NASDAQ: RELV), a maker of nutritional supplements that promote optimal health, today reported its financial results for the third quarter of 2015.
RELV: 0.57 (-0.06)

Reliv Videos Reach One Million Views Online
Marketwired - Mon Oct 19, 1:46PM CDT
Reliv International, Inc. (NASDAQ: RELV), a maker of nutritional supplements that promote optimal health, today announced that its online video catalog has totaled over one million cumulative views across all platforms. Platforms include YouTube, Facebook and Reliv websites.
RELV: 0.57 (-0.06)

Update - Reliv International Announces New Banking Relationship
Marketwired - Fri Oct 02, 9:33AM CDT
Reliv International, Inc. (NASDAQ: RELV), a maker of nutritional supplements that promote optimal health, today announced that it had entered into a new banking relationship with Enterprise Bank and Trust, based in St. Louis, Missouri.
RELV: 0.57 (-0.06)

Reliv International Announces New Banking Relationship
Marketwired - Fri Oct 02, 6:01AM CDT
Reliv International, Inc. (NASDAQ: RELV), a maker of nutritional supplements that promote optimal health, today announced that it had entered into a new banking relationship with Enterprise Bank and Trust, based in St. Louis, Missouri.
RELV: 0.57 (-0.06)

Reliv Strengthens LunaRich Patent for Cholesterol Lowering
Marketwired - Tue Aug 18, 3:05PM CDT
Reliv International, Inc. (NASDAQ: RELV), a maker of nutritional supplements that promote optimal health, today announced that the U.S. Patent and Trademark Office has issued an expanded patent for LunaRich®, Reliv's exclusive nutritional ingredient. The updated patent further protects LunaRich technology as it relates to the soy peptide lunasin's mechanism of action for lowering LDL cholesterol levels.
RELV: 0.57 (-0.06)

Reliv International widens loss in Q2 2015
M2 - Mon Aug 17, 4:53AM CDT
Reliv International Inc (Nasdaq:RELV) on Friday reported a net loss of USD846,000, or USD0.07 per diluted share, for the second quarter of 2015, ended 30 June 2015.
RELV: 0.57 (-0.06)

Reliv International Reports Second-Quarter Financial Results
Marketwired - Fri Aug 14, 6:00AM CDT
Reliv International, Inc. (NASDAQ: RELV), a maker of nutritional supplements that promote optimal health, today reported its financial results for the second quarter of 2015.
RELV: 0.57 (-0.06)

Reliv Kalogris Foundation Turns 20
Marketwired - Mon Aug 10, 11:29AM CDT
The Reliv Kalogris Foundation (RKF) this week celebrates its 20thanniversary as the charitable arm of Reliv International (NASDAQ: RELV). The milestone was marked with a special ceremony on Saturday as part of the 2015 Reliv International Conference at America's Center in downtown St. Louis.
RELV: 0.57 (-0.06)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Investors of Sage Therapeutics Have Chance to Join Lawsuit

Updated Category News Views 88

Introduction to the Class Action Lawsuit Attention, investors! There's an important opportunity arising for shareholder litigation against Sage Therapeutics, Inc. The legal firm Bronstein, Gewirtz & Grossman, LLC is officially notifying individuals who have invested in Sage Therapeutics about a class action lawsuit that has now been filed. If you have faced substantial...

Continue Reading
FARO Technologies Revolutionizes 3D Metrology with Leap ST

Updated Category News Views 105

FARO Technologies Enhances 3D Metrology with Leap ST FARO Technologies, Inc. (NASDAQ: FARO) is pushing the boundaries of handheld scanning technology with the introduction of the Leap ST. This launch marks a significant expansion of FARO's product portfolio, positioning the company among the few firms offering a comprehensive range of portable 3D metrology solutions. Leap...

Continue Reading
Strong Financial Performance and Growth Strategies at TORM PLC

Updated Category News Views 181

TORM PLC Reports Robust Q3 2025 Financial Results TORM PLC has demonstrated remarkable resilience and adaptability, reporting its strongest quarterly results in 2025. This achievement underscores the effectiveness of TORM's integrated operating model, as highlighted by the CEO. The company continues to prioritize creating long-term value for its shareholders while...

Continue Reading
Manhattan Associates Faces Legal Challenges Amid Shareholder Losses

Updated Category News Views 304

Manhattan Associates Faces Legal Challenges Following Shareholder Loss In recent developments, Manhattan Associates, Inc. (NASDAQ: MANH) is under scrutiny as a class action lawsuit has been filed against the company. This action comes after an alarming drop in shareholder value, amounting to over $4 billion. The lawsuit is pivotal as it involves allegations of misleading...

Continue Reading
BioLife Solutions Announces Upcoming Financial Results

Updated Category News Views 91

BioLife Solutions to Share Key Financial Insights BioLife Solutions, Inc. (NASDAQ: BLFS), a pioneering developer and supplier of bioproduction products and services specializing in cell and gene therapies, is gearing up for a significant event. The company plans to release its financial results for the third quarter of 2024 after market hours on November 12, 2024. This is...

Continue Reading